Cysteine-rich protein 2, a novel downstream effector of cGMP/cGMP-dependent protein kinase I-mediated persistent inflammatory pain

Journal of Neuroscience

Volumn 28, Issue 6, 2008, Pages 1320-1330

  Schmidtko, Achim ^a   Gao, Wei ^a   Sausbier, Matthias ^b   Rauhmeier, Inga ^a   Sausbier, Ulrike ^b   Niederberger, Ellen ^a   Scholich, Klaus ^a   Huber, Andrea ^c   Neuhuber, Winfried ^d   Allescher, Hans Dieter ^e   Hofmann, Franz ^c   Tegeder, Irmgard ^a   Ruth, Peter ^b   Geisslinger, Gerd ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Pharmazeutisches Institut   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e Klinikum Garmisch Partenkirchen   (Germany)

Author keywords

cGKI; CRP2; DRG; Knock out mice; Pain behavior; Spinal cord

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; CYSTEIN RICH PROTEIN 2; CYSTEINE; ISOLECTIN B4; LECTIN; PERIPHERIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CONTROLLED STUDY; INFLAMMATION; INFLAMMATORY PAIN; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SCIATIC NERVE; SIGNAL TRANSDUCTION; SPINAL CORD;

ANIMALS; CHRONIC DISEASE; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; GANGLIA, SPINAL; INFLAMMATION MEDIATORS; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; NUCLEAR PROTEINS; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 38949101625     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5037-07.2008     Document Type: Article

References (51)

1. Alvarez FJ, Fyffe RE (2000) Nociceptors for the 21st century. Curr Rev Pain 4:451-458.
2. Arber S, Halder G, Caroni P (1994) Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 79:221-231.
3. Ausubel FM (2003a) Yeast. In: Current protocols in molecular biology (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds), pp 13.1.1-13.13.7. New York: Wiley.
4. Ausubel FM (2003b) Analysis of protein interactions. In: Current protocols in molecular biology (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds), pp 20.1.1-20.1.33. New York: Wiley.
5. Averill S, McMahon SB, Clary DO, Reichardt LF, Priestley JV (1995) Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur J Neurosci 7:1484-1494.
6. Bennett MK, Calakos N, Scheller RH (1992) Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 257:255-259.
7. Butt E, Nolte C, Schulz S, Beltman J, Beavo JA, Jastorff B, Walter U (1992) Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem Pharmacol 43:2591-2600.
8. Crawley JN (2003) Behavioral phenotyping of rodents. Comp Med 53:140-146.
9. Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87:149-158.
10. Ferreira J, Campos MM, Pesquero JB, Araujo RC, Bader M, Calixto JB (2001) Evidence for the participation of kinins in Freund's adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice. Neuropharmacology 41:1006-1012.
11. Gietz RD, Schiestl RH, Willems AR, Woods RA (1995) Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast 11:355-360.
12. Goldstein ME, House SB, Gainer H (1991) NF-L and peripherin immuno-reactivities define distinct classes of rat sensory ganglion cells. J Neurosci Res 30:92-104.
13. Hofmann F, Feil R, Kleppisch T, Schlossmann J (2006) Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 86:1-23.
14. Huang J, Chang JY, Woodward DJ, Baccala LA, Han JS, Wang JY, Luo F (2006) Dynamic neuronal responses in cortical and thalamic areas during different phases of formalin test in rats. Exp Neurol 200:124-134.
15. Huber A, Neuhuber WL, Klugbauer N, Ruth P, Allescher HD (2000) Cysteine-rich protein 2, a novel substrate for cGMP kinase I in enteric neurons and intestinal smooth muscle. J Biol Chem 275:5504-5511.
16. Hunskaar S, Fasmer OB, Hole K (1985) Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods 14:69-76.
17. Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413:203-210.
18. Kim SJ, Calejesan AA, Li P, Wei F, Zhuo M (1999) Sex differences in late behavioral response to subcutaneous formalin injection in mice. Brain Res 829:185-189.
19. Liebhaber SA, Emery JG, Urbanek M, Wang XK, Cooke NE (1990) Characterization of a human cDNA encoding a widely expressed and highly conserved cysteine-rich protein with an unusual zinc-finger motif. Nucleic Acids Res 18:3871-3879.
20. Lin Q, Peng YB, Wu J, Willis WD (1997) Involvement of cGMP in nociceptive processing by and sensitization of spinothalamic neurons in primates. J Neurosci 17:3293-3302.
21. Meller ST, Gebhart GF (1993) Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52:127-136.
22. Meller ST, Gebhart GF (1997) Intraplantar zymosan as a reliable, quantifiable model of thermal and mechanical hyperalgesia in the rat. Eur J Pain 1:43-52.
23. Michael GJ, Averill S, Nitkunan A, Rattray M, Bennett DL, Yan Q, Priestley JV (1997) Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 17:8476-8490.
24. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M (1999) Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 80:67-82.
25. Okano I, Yamamoto T, Kaji A, Kimura T, Mizuno K, Nakamura T (1993) Cloning of CRP2, a novel member of the cysteine-rich protein family with two repeats of an unusual LIM/double zinc-finger motif. FEBS Lett 333:51-55.
26. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, Hofmann F (1998) Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17:3045-3051.
27. Porro CA, Cavazzuti M, Lui F, Giuliani D, Pellegrini M, Baraldi P (2003) Independent time courses of supraspinal nociceptive activity and spinally mediated behavior during tonic pain. Pain 104:291-301.
28. Qian Y, Chao DS, Santillano DR, Cornwell TL, Nairn AC, Greengard P, Lincoln TM, Bredt DS (1996) cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J Neurosci 16:3130-3138.
29. Salter M, Strijbos PJ, Neale S, Duffy C, Follenfant RL, Garthwaite J (1996) The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway. Neuroscience 73:649-655.
30. Schaffer S (2006) Investigations about the function of the cGMP-dependent kinase I alpha during the development of the nervous system (in German). Berlin: Freie Universität Berlin.
31. Schmidt H, Werner M, Heppenstall PA, Henning M, More MI, Kuhbandner S, Lewin GR, Hofmann F, Feil R, Rathjen FG (2002) cGMP-mediated signaling via cGKIalpha is required for the guidance and connectivity of sensory axons. J Cell Biol 159:489-498.
32. Schmidtko A, Ruth P, Geisslinger G, Tegeder I (2003) Inhibition of cyclic guanosine 5′-monophosphate-dependent protein kinase I (PKG-I) in lumbar spinal cord reduces formalin-induced hyperalgesia and PKG upregulation. Nitric Oxide 8:89-94.
33. Schmidtko A, Del Turco D, Coste O, Ehnert C, Niederberger E, Ruth P, Deller T, Geisslinger G, Tegeder I (2005) Essential role of the synaptic vesicle protein synapsin II in formalin-induced hyperalgesia and glutamate release in the spinal cord. Pain 115:171-181.
34. Schnell SA, Staines WA, Wessendorf MW (1999) Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 47:719-730.
35. Scholz J, Woolf CJ (2002) Can we conquer pain? Nat Neurosci 5 [Suppl]:1062-1067.
36. Schubert W, Bonnekoh B, Pommer AJ, Philipsen L, Bockelmann R, Malykh Y, Gollnick H, Friedenberger M, Bode M, Dress AW (2006) Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat Biotechnol 24:1270-1278.
37. Schwede F, Maronde E, Genieser H, Jastorff B (2000) Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol Ther 87:199-226.
38. Silverman JD, Kruger L (1990) Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markers. J Neurocytol 19:789-801.
39. Song XJ, Wang ZB, Gan Q, Walters ET (2006) cAMP and cGMP contribute to sensory neuron hyperexcitability and hyperalgesia in rats with dorsal root ganglia compression. J Neurophysiol 95:479-492.
40. Sung YJ, Chiu DT, Ambron RT (2006) Activation and retrograde transport of protein kinase G in rat nociceptive neurons after nerve injury and inflammation. Neuroscience 141:697-709.
41. Tao YX, Johns RA (2000) Activation of cGMP-dependent protein kinase Ialpha is required for N-methyl-D-aspartate- or nitric oxide-produced spinal thermal hyperalgesia. Eur J Pharmacol 392:141-145.
42. Tao YX, Johns RA (2002) Activation and up-regulation of spinal cord nitric oxide receptor, soluble guanylate cyclase, after formalin injection into the rat hind paw. Neuroscience 112:439-446.
43. Tao YX, Hassan A, Haddad E, Johns RA (2000) Expression and action of cyclic GMP-dependent protein kinase Ialpha in inflammatory hyperalgesia in rat spinal cord. Neuroscience 95:525-533.
44. Tegeder I, Schmidtko A, Niederberger E, Ruth P, Geisslinger G (2002) Dual effects of spinally delivered 8-bromo-cyclic guanosine mono-phosphate (8-bromo-cGMP) in formalin-induced nociception in rats. Neurosci Lett 332:146-150.
45. Tegeder I, Del Turco D, Schmidtko A, Sausbier M, Feil R, Hofmann F, Deller T, Ruth P, Geisslinger G (2004) Reduced inflammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase I. Proc Natl Acad Sci USA 101:3253-3257.
46. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992) The formalin test: an evaluation of the method. Pain 51:5-17.
47. Wallace VC, Cottrell DF, Brophy PJ, Fleetwood-Walker SM (2003) Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behavior that is attenuated by cannabinoids. J Neurosci 23:3221-3233.
48. Wei F, Wang GD, Kerchner GA, Kim SJ, Xu HM, Chen ZF, Zhuo M (2001) Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 4:164-169.
49. Weiskirchen R, Pino JD, Macalma T, Bister K, Beckerle MC (1995) The cysteine-rich protein family of highly related LIM domain proteins. J Biol Chem 270:28946-28954.
50. Woolf CJ (1983) Evidence for a central component of post-injury pain hypersensitivity. Nature 306:686-688.
51. Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765-1769.